Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00787371
What this trial is testing

Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 69
Testing effectiveness (Phase 2)Study completedNCT02457611
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection

Who this might be right for
Hepatitis C Infection With HIV Co-Infection
Gilead Sciences 26
Post-approval studies (Phase 4)Study completedNCT00686777
What this trial is testing

Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 75
Testing effectiveness (Phase 2)Study completedNCT00743795
What this trial is testing

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Who this might be right for
HCV Infection
Gilead Sciences 252
Not applicableUnknownNCT04585165
What this trial is testing

User-friendly HIV Testing and Counseling Services

Who this might be right for
HIV InfectionsSexually Transmitted InfectionHepatitis B, Chronic+1 more
Institut de Recherche pour le Developpement 3,000
Testing effectiveness (Phase 2)Study completedNCT02133131
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 143
Not applicableStudy completedNCT02943330
What this trial is testing

Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life

Who this might be right for
HemodialysisHepatitis C
Chang Gung Memorial Hospital 170
Early research (Phase 1)WithdrawnNCT00956722
What this trial is testing

Hyperimmune Bovine Colostrum - TRAVELAN™ for Patients With Chronic Hepatitis C Virus Infection Not Responding to Standard Therapy

Who this might be right for
Asymptomatic Chronic HCV Carriers
Hadassah Medical Organization
Large-scale testing (Phase 3)Study completedNCT02114177
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Janssen Infectious Diseases BVBA 310
Not applicableStudy completedNCT01335230
What this trial is testing

The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients

Who this might be right for
HIVHepatitis C, ChronicHCV Coinfection
University of Cincinnati 40
Not applicableStudy completedNCT01850745
What this trial is testing

Multidisciplinary Support Program in Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Parc de Salut Mar 447
Early research (Phase 1)Study completedNCT01337375
What this trial is testing

The Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 31
Not applicableStudy completedNCT04202081
What this trial is testing

Voices From the Black Community: Hepatitis C Research Participation

Who this might be right for
Hepatitis C, Chronic
University of North Carolina, Chapel Hill 200
Testing effectiveness (Phase 2)Study completedNCT00968357
What this trial is testing

Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed

Who this might be right for
Chronic Hepatitis C
SciClone Pharmaceuticals 40
Large-scale testing (Phase 3)Study completedNCT04382937
What this trial is testing

Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
PharmaEssentia 222
Testing effectiveness (Phase 2)Study completedNCT00943761
What this trial is testing

Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 45
Not applicableActive Not RecruitingNCT07316842
What this trial is testing

SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF

Who this might be right for
Viral Hepatitis C
Center of target therapy 30
Large-scale testing (Phase 3)Study completedNCT02640157
What this trial is testing

A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusGenotype 3 Hepatitis C Virus
AbbVie 506
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Large-scale testing (Phase 3)Study completedNCT02201953
What this trial is testing

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 558
Next Page